Viroclinics-DDL, with its three specialty laboratory and office locations in the Netherlands, has been part of the Cerba Research group since early 2022. By fully entering into the brand now, the company underscores its collective focus and dedication to the advancement of clinical research together. This move marks a natural step forward in the company’s mission to accelerate the development of life-saving therapies.